Basavatarakam Indo American Cancer Hospital & Research Institute
- Company typePrivate
- Founded2000
- HeadquartersHyderabad, India
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
Basavatarakam Indo American Cancer Hospital & Research Institute firmographics
Firmographics- Name
- Basavatarakam Indo American Cancer Hospital & Research Institute
- Legal name
- Basavatarakam Indo American Cancer Hospital & Research Institute
- Website
- https://induscancer.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
Basavatarakam Indo American Cancer Hospital & Research Institute industry classification
Industry- Product category
- Oncology Healthcare Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
- SIC
- Services-Hospitals (8060), Services-Health Services (8000)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)
Keywords
Where Basavatarakam Indo American Cancer Hospital & Research Institute is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Basavatarakam Indo American Cancer Hospital & Research Institute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Patient Treatment Services: Healthcare services provided to patients including surgical, medical, and radiation oncology treatments. The hospital is a non-profit trust providing world-class cancer treatment at affordable prices, with significant funds allocated annually for underprivileged patients.
- Government Healthcare Schemes: Reimbursements from government schemes such as Aarogyasri and Employee Health Scheme for eligible patients.
- Donations and Charitable Contributions: Donations from individuals, trusts, foundations, and organizations supporting the hospital's mission of affordable cancer care.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | General Patient Services |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels8 records
Basavatarakam Indo American Cancer Hospital & Research Institute product offering
Product offeringCore offering
Basavatarakam Indo American Cancer Hospital & Research Institute is a nonprofit trust cancer hospital providing comprehensive cancer diagnosis, treatment, and research services including surgical oncology, medical oncology, and radiation oncology. The hospital operates advanced medical technology including PET CT with Cyclotron, Tomotherapy, robotic surgery systems, and six linear accelerators. It also runs a Bone Marrow Transplant unit, dedicated international patient coordination, DNB/PG medical training programs, and nursing and paramedical education, supported by scientific collaboration with Weill Cornell and Presbyterian Hospital, New York.
Product overview
Basavatarakam Indo American Cancer Hospital & Research Institute is a nonprofit trust cancer hospital offering comprehensive cancer care through an integrated multi-disciplinary approach. The hospital provides a unified suite of oncology services organized into three core treatment streams: Surgical Oncology, Medical Oncology, and Radiation Oncology (with scientific support from Weill Cornell and Presbyterian Hospital, New York). These core services are supported by advanced diagnostic imaging technologies (PET CT with Cyclotron, SPECT, 3D Digital Mammography/Tomosynthesis, Gamma Camera Scan), cutting-edge treatment equipment (6 Linear Accelerators including Varian Novalis Tx with Rapid Arc/VMAT/Brain Lab, Tomotherapy, Robotic Surgery, Versa HD, Brachytherapy, IORT), and a state-of-the-art Bone Marrow Transplant unit. The hospital also offers digital patient services including online appointment booking across all departments and a Cancer Risk Assessment WebApp. Education and research divisions offer DNB/PG programs, nursing education (School and College of Nursing), and paramedical courses. International patient services with dedicated coordination are also available.
Differentiator
Problem solved
Functional benefit
Products and services
- Surgical Oncology
Quantifiable outcome
- 250,925+ individuals screened through 1,339 screening camps
- +2 more outcomes
Companies that use Basavatarakam Indo American Cancer Hospital & Research Institute
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Basavatarakam Indo American Cancer Hospital & Research Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Basavatarakam Indo American Cancer Hospital & Research Institute partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Weill Cornell and Presbyterian Hospital, New YorkcoreScientific support provided to the Radiation Oncology department since its inception in 2000, enhancing treatment protocols and expertise.
- Varian Medical SystemscoreMajor donor providing advanced radiation therapy equipment and technology support for the hospital's radiation oncology department.
- Indo American Cancer Organisation (U.S.A.)coreFounding donor and strategic partner supporting the establishment and mission of the hospital as a joint Indo-American initiative.
- ADK Medical Centre, MaldivesminorInternational referral partner sending patients to the hospital for advanced cancer treatment.
- Case Medical Centre, UgandaminorInternational referral partner sending patients to the hospital for advanced cancer treatment.
- St. Catherine's Hospital, UgandaminorInternational referral partner sending patients to the hospital for advanced cancer treatment.
- Grande Hospital, NepalminorInternational referral partner sending patients to the hospital for advanced cancer treatment.
- AK Global Health, USAminorInternational healthcare referral partner in the USA connecting patients with the hospital's services.
- National Board of Examination, New DelhicoreRecognizes the hospital for conducting DNB/PG programmes for doctors in various oncology specializations.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Basavatarakam Indo American Cancer Hospital & Research Institute competitors and assessment
Company assessmentBroad incumbents
- Max Institute of Cancer Care: Multi-specialty hospital group with dedicated cancer programs across North India offering radiation oncology, BMT, and surgical oncology — comparable in technology and academic depth but as part of a listed for-profit chain.
- Apollo Cancer Centre (Apollo Hospitals): Large hospital chain with dedicated cancer centers across India including Hyderabad, offering surgical, medical, and radiation oncology with PET CT, LINACs, and BMT — comparable services but as part of a multi-specialty for-profit group with broader footprint.
- Cancer Treatment Centers of America / City of Hope: US-based specialty oncology network (now part of City of Hope) offering integrated cancer care with strong translational research and academic programs — analogous in mission to integrate research, training, and multi-modality cancer treatment.
- Medanta - The Medicity (Cancer Institute): Multi-specialty tertiary hospital in Gurugram/Delhi NCR with dedicated cancer care division including radiation, medical, and surgical oncology — comparable in equipment breadth (LINACs, PET CT, robotic surgery) but with broader non-oncology portfolio.
Others
- Cancer Aid Society / Indian Cancer Society: Indian non-profit organizations focused on cancer awareness, screening camps, and patient support — adjacent peer reflecting the charitable cancer-care ecosystem that BIACH participates in for community outreach and underprivileged patient funding.
Direct peers
- Tata Memorial Hospital: India's premier public specialty cancer hospital based in Mumbai, offering comprehensive surgical, medical, and radiation oncology with extensive research and DNB training programs — directly comparable in scope, mission, and academic depth to BIACH.
- HCG (HealthCare Global Enterprises): India's largest cancer hospital chain with multiple centers including Hyderabad, specializing in medical, surgical, and radiation oncology with advanced LINAC fleets and BMT — closest pure-play oncology network peer in scale and tech stack.
- Rajiv Gandhi Cancer Institute and Research Centre: Not-for-profit specialty cancer hospital in Delhi offering comprehensive oncology services, NABH accreditation, and academic programs — a close analogue in nonprofit trust structure and tertiary cancer care scope.
- AIIMS (All India Institute of Medical Sciences) - Oncology Centre: Premier public academic medical institution with dedicated cancer treatment facilities (Dr. B.R.A. IRCH) in Delhi — comparable in academic mission, subsidized care, and tertiary oncology scope as a public-sector trust analogue.
Regional players
- Basel Cancer Institute (University Hospital Basel): European specialty cancer center combining clinical care, research, and teaching — a useful cross-regional benchmark for academic comprehensive cancer center operations though it serves a different geography.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Basavatarakam Indo American Cancer Hospital & Research Institute social profiles
Digital presenceBasavatarakam Indo American Cancer Hospital & Research Institute compliance and trust
Trust signalCompliance6 records
Basavatarakam Indo American Cancer Hospital & Research Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Basavatarakam Indo American Cancer Hospital & Research Institute leadership team
Management profileNumber of profiles
Basavatarakam Indo American Cancer Hospital & Research Institute subsidiaries and ownership
Company hierarchySubsidiaries3 records
Basavatarakam Indo American Cancer Hospital & Research Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Basavatarakam Indo American Cancer Hospital & Research Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Basavatarakam Indo American Cancer Hospital & Research Institute
What does Basavatarakam Indo American Cancer Hospital & Research Institute do?
Basavatarakam Indo American Cancer Hospital & Research Institute is a nonprofit trust cancer hospital providing comprehensive cancer diagnosis, treatment, and research services including surgical oncology, medical oncology, and radiation oncology. The hospital operates advanced medical technology including PET CT with Cyclotron, Tomotherapy, robotic surgery systems, and six linear accelerators. It also runs a Bone Marrow Transplant unit, dedicated international patient coordination, DNB/PG medical training programs, and nursing and paramedical education, supported by scientific collaboration with Weill Cornell and Presbyterian Hospital, New York.
Is Basavatarakam Indo American Cancer Hospital & Research Institute a public or private company?
Basavatarakam Indo American Cancer Hospital & Research Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Basavatarakam Indo American Cancer Hospital & Research Institute founded?
Basavatarakam Indo American Cancer Hospital & Research Institute was founded in 2000. It employs 5,001 to 10,000 people.
Where is Basavatarakam Indo American Cancer Hospital & Research Institute based?
Basavatarakam Indo American Cancer Hospital & Research Institute is headquartered in Hyderabad, India, in the Asia region.
How does Basavatarakam Indo American Cancer Hospital & Research Institute make money?
Three revenue lines are on record. Patient Treatment Services are the primary driver. The others are government Healthcare Schemes and donations and Charitable Contributions.
Who are Basavatarakam Indo American Cancer Hospital & Research Institute's main competitors?
Broad incumbents on record are Max Institute of Cancer Care, Apollo Cancer Centre (Apollo Hospitals), Cancer Treatment Centers of America / City of Hope and Medanta - The Medicity (Cancer Institute). Cancer Aid Society / Indian Cancer Society is listed as an others. Direct peers are Tata Memorial Hospital, HCG (HealthCare Global Enterprises), Rajiv Gandhi Cancer Institute and Research Centre and AIIMS (All India Institute of Medical Sciences) - Oncology Centre. Basel Cancer Institute (University Hospital Basel) is listed as a regional player.
Does Basavatarakam Indo American Cancer Hospital & Research Institute have an API?
No public API is recorded for Basavatarakam Indo American Cancer Hospital & Research Institute.
What industry is Basavatarakam Indo American Cancer Hospital & Research Institute in?
Basavatarakam Indo American Cancer Hospital & Research Institute's product category is Oncology Healthcare Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8060.